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Abstract.  The  article  presents  some  general  facts  about  omega-3  fatty  acids  and  their  role  in  the 
treatment and prevention of cardiovascular diseases. Omega-3 fatty acids are essential for the human 
body. Their beneficial effects in the prevention of cardiovascular disease have been known for decades. 
Since then, several epidemiological and interventional trials showed the value of omega-3 acids in the 
treatment of certain diseases. Most of them revealed the protective role of omega-3 fatty acids on heart 
and  cardiac  functions.  However,  some  of  these  studies  couldn’t  demonstrate  a  positive  association 
between fish oils and preventing cardiac events. The major cardiologic societies from European Union 
and  United  States  of  America  recommend  omega-3  fatty  acids  as  supplements  for  primary  and 
secondary prophylaxis of cardiovascular diseases.   
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Resumen.  El  articulo  presenta  datos  generales  sobre  ácidos  grasos  omega-3  y  sus  papel  en  el 
tratamiento y en la prevención de las enfermedades cardiovasculares. Los ácidos grasos omega-3 son 
esenciales  para  el  cuerpo  humano.  Sus  efectos  beneficos  en  la  prevención  de  las  enfermedades 
cardiovasculares  son  conocidos  desde  decenios.  Desde  entonces,  unas  pruebas  epidemiologicas  y 
terapeuticas  enseñaron  la  importancia  de  los  ácidos  grasos  omega-3  en  los  tratamiento  de  algunas 
enfermedades.  La  mayoria  han  relevado  el  papel  protector  de  los  ácidos  grasos  omega-3  sobre  la 
corazon y sobre sus funciones circulatorias. Otros estudios no han señalado una relación entre el aceite 
de pescado y la prevención de los casos de infarto. Las más importantes asociaciones de cardiologia de 
la Unión Europea y de los Estados Unidos recomiendan la utilización de los ácidos grasos omega-3 como 
suplemento en la prevención primaria y secundaria de las enfermedades cardiovasculares.  
Palabras  claves:  ácidos  grasos  omega-3,  enfermedades  cardiovasculares,  factor  protector, 
recomendaciones nutricionales. 
 
Rezumat. Articolul prezintă câteva date generale despre acizii graşi omega-3 şi rolul lor în tratamentul 
şi prevenirea bolilor cardiovasculare. Acizii graşi omega-3 sunt esenţiali pentru corpul uman. Efectele lor 
benefice în prevenirea bolilor cardiovasculare sunt cunoscute de câteva decenii. De atunci, câteva trialuri 
epidemiologice  şi  intervenţionale  au  arătat  valoarea  acizilor  omega-3  în  tratamentul  unor  boli. 
Majoritatea au relevat rolul protector al acizilor omega-3 asupra inimii și funcției circulatorii. Altele nu au 
găsit o corelație între uleiul de peşte şi prevenirea evenimentelor cardiace. Societăţile mari de cardiologie 
din Uniunea Europeană şi Statele Unite ale Americii recomandă acizii graşi omega-3 ca şi supliment în 
profilaxia primară şi secundară a bolilor cardiovasculare. 
Cuvinte cheie: acizi graşi omega-3, boli cardiovasculare, factor protector, recomandări alimentare. 
 
 
Introduction.  Omega-3  (n-3)  fatty  acids  are  a  family  of  polyunsaturated  fatty  acids 
(PUFAs) that  have  in  common  a  carbon-carbon  double  bond  in  the n-3  position.  The 
major sources of omega-3 fatty acids are fish oils (EPA - eicosapentaenoic acid, DHA - 
docosahexaenoic acid) and plants (ALA - α-linolenic acid). ALA was first isolated from 
hempseed  oil  in  1887  (Deuel  1951).  In  1970,  the  results  of  a  study  on  the  Eskimo 
population  in  North-Western  Greenland  revealed  a  lower  concentration  in  seric 
cholesterol and triglycerides, as compared to Danish controls. The major finding was the 
replacement of omega-6 fatty acids with omega-3 fatty acids (Bang et al 1971). Several 
years later, a study linked this replacement to the Eskimo’s diet, which consisted mainly 
in fish (Bang et al 1976). The benefits of a diet based on fish are explained by the rich   138 
intake in very long chain, highly polyunsaturated omega-3 fatty acids (EPA and DHA). 
Since  then,  several  trials  studied  the  effect  of  omega-3  fatty  acids  on  various 
pathologies.  
 
General  information.  Omega-3 fatty  acids  are  essential  for the  human  body,  which 
cannot  synthesize  them  de  novo.  There  are  three  important  omega-3  fatty  acids:  α-
linolenic  acid  [(ALA),  18  carbons,  3  double  bonds],  eicosapentaenoic  acid  [(EPA),  20 
carbons,  5  double  bonds)]  and  docosahexaenoic  acid  [(DHA),  22  carbons,  6  double 
bonds]. ALA is an essential fatty acid because it cannot
  be synthesized in the human 
body  from  saturated  fatty  acids,  n–9  monounsaturated
  fatty  acids,  or  n–6 
polyunsaturated fatty acids (PUFAs).
 Humans lack the desaturase that inserts a double 
bond at the
 C-15 position of a fatty acid carbon chain (Gebauer et al 2006). EPA and DHA 
are synthesized in the human body from ALA but with relatively low conversions so that 
diet is the main source also for these two fatty acids.  
Omega-3 and omega-6 acids are essential for normal growth and development of 
the human body. Omega-6 fatty acids contain a carbon-carbon double bond between the 
6
th and 7
th carbon atoms from the methyl end of the fatty acid. An insufficient intake of 
omega-3  acids  may  lead  to  hemorrhagic  dermatitis,  hemorrhagic  folliculitis,  impaired 
wound healing, growth retardation. These fatty acids are found in high concentration in 
the brain and are important for memory, physic performance and behavior. Newborns 
from mothers who do not get enough omega-3 acids during pregnancy, are susceptible 
to develop vision and nervous system problems. In addition, there have been several 
studies that proved the beneficial effect of the consumption of omega-3 fatty acids on 
cardiovascular diseases, psychiatric disorders, cancer and other conditions. Omega-3 and 
omega-6 fatty acids compete for the same enzymes. A balance between the intake of 
omega-3 and omega-6 fatty acids is necessary for maximizing the benefits of these fats. 
High levels of omega-6 fatty acids are dangerous because they increase the probability of 
cardiovascular diseases. Omega-3 fatty acids help to reduce inflammation, and omega-6 
acids promote the inflammation. The typical Western diet includes a ratio of omega-6 to 
omega-3 of 10:1. The optimal ratio is closer to 4:1 (Simopoulos 2002). 
EPA and DHA are found in cold-water fish such as tuna, sprat, mackerel, herring, 
anchovy,  salmon,  sardines  and  cod  (see  Table  1).  Fish  get  their  EPA  and  DHA  from 
marine algae (Brunner at al 2008). ALA is found in flaxseeds, flaxseed oil, rapeseed oil, 
soybeans, soybean oil, pumpkins seeds, perilla seed oil, walnuts, and black raspberries. 
Microalgae Crypthecodinium cohnii and Schizochytrium are rich sources of DHA, but poor 
sources of EPA (see Table 2 for vegetal sources of omega-3 fatty acids).  
 
Table 1 
Fish sources of omega-3 fatty acids. 
Serving size: 100 g, cooked 
 
Fish  EPA + DHA content (g/Serving)  Calories/Serving 
Farmed salmon  2.15  206 
Atlantic herring  2.01  203 
Wild salmon  1.84  182 
Sardine, canned in tomato sauce  1.35  186 
Atlantic mackerel  1.20  262 
Farmed rainbow trout  1.15  169 
Wild rainbow trout  0.98  150 
White tuna, canned in water  0.86  128 
Halibut  0.47  140 
Shrimp  0.32  99 
Fresh yellowfin tuna  0.28  139 
Light tuna, canned in water  0.27  116 
Atlantic cod  0.16  105 
Sources: www.nal.usda.gov/fnic/foodcomp/search, www.nutritiondata.com, U.S. Food and Drug Administration. 
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Cardiovascular  implications  of  omega-3  fatty  acids.  Since  1970,  several  trials 
studied  the  effects  of  omega-3  fatty  acids  on  various  diseases  with  some  degree  of 
success:  cardiovascular  illnesses,  diabetes,  obesity,  hypercholesterolemia,  rheumatoid 
arthritis,  osteoporosis,  depression,  bipolar  disorders,  schizophrenia,  attention 
deficit/hyperactivity disorder, burns, inflammatory bowel disease, asthma, cancer. The 
strongest evidence of the beneficial effects of omega-3 fatty acids were obtained in the 
case of heart diseases. 
 
Table 2 
Plant sources of omega-3 fatty acids 
 
Food  Amount  Omega-3 fatty 
acid (g/serving 
Fiber 
(g/serving) 
Calories/Serving 
Flax oil  1 tbs*  7.249  n/a  120 
Ground flaxseed  1 tbs  1.597  1.9  37 
English walnuts  1 tbs  1.29  0.9  93 
Soy oil  1 tbs  0.94  n/a  120 
Canola oil  1 tbs  0.862  n/a  120 
Tofu, raw, firm  ½ cup  0.733  2.9  183 
Green soybeans, cooked  ½ cup  0.319  3.8  127 
Navy beans, cooked  1 cup  0.213  19.1  255 
Wheat germ  ¼ cup  0.208  3.8  104 
Avocado raw  1 cup  0.182  9.8  234 
Black walnuts  1 tbs  0.155  0.5  48 
Kidney beans, canned  1 cup  0.125  19.1  210 
Baked beans, canned  1 cup  0.104  10.4  239 
* tbs = tablespoon 
Sources: www.nal.usda.gov/fnic/foodcomp/search, www.nutritiondata.com, U.S. Food and Drug Administration. 
 
 
There are several mechanisms potentially responsible for the effect of omega-3. EPA and 
DHA,  like  other  fatty  acids,  integrate  themselves  into  the  cell  membrane,  replacing 
unsaturated  fatty  acids.  Once  incorporated  in  the  membrane,  they  modulate  cellular 
function  (Harris  2005).  The  omega-3  fatty  acids  decrease  the  level  of  intracellular 
calcium  by  blocking  the  calcium  release  channels  of  the  sarcoplasmic  reticulum,  by 
remodeling the L-type calcium current or by inhibition of Na
+ channels.  This shortens the 
action potential of the myocytes, directly
 altering the automaticity or responsiveness of 
the  sinus  node,  which  can  reduce  the  incidence  of  arrhythmias  (Kang  et  al  2000; 
Mozaffarian et al 2005; Den Ruijter et al 2008).  
Sudden cardiac death is one of the most common first manifestations of coronary 
heart disease. It is responsible
 for nearly half of all mortality caused by cardiovascular 
disorders
  in  the  Western  world  (Zipes  et  al  1998)  Investigators  from  The  Study  on 
Omega-3 Fatty
 acids and ventricular Arrhythmia (SOFA) studied the effect of omega-3 
fatty  acids  on  patients  with  implantable
  cardioverter-defibrillators  and  found  that  the 
intake of fish oils reduced the risk of sudden death by 36%. Compared to the rate of 
death in the placebo group, this value was too small to prove that omega-3 fatty acids 
have a strong
 protective effect against
 ventricular arrhythmia in patients with implantable
 
cardioverter-defibrillators  (Brouwer  et  al  2006).  Another  trial,  GISSI-Prevenzione 
(Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico) found that a 
diet  rich  in  omega-3  fatty  acids  is  linked  to  a  14%  reduction  in  death,  non-fatal 
myocardial infarction, and stroke and to a 20% decrease in cardiovascular death (GISSI-
Prevenzione 1999). Results of Zutphen study showed that long-term fish consumption 
was  inversely  correlated  (borderline
  significant)  with  (sudden)  coronary  heart  disease 
death, however,
 the strength of the correlation decreased with age (Streppel et al 2008).  
The acute administration of EPA and DHA determined the reduction of ventricular 
tachycardias in patients with implanted defibrillator (Schrepf et al 2004). Also, in these 
patients,  omega-3  acids  prolonged  the  time  to  the  first  major  arrhythmic  episode   140 
(ventricular tachycardia or fibrillation) (Leaf et al 2005). In patients undergoing coronary 
bypass grafting, EPA and DHA
 suppressed the onset of new atrial fibrillation (Calo et al 
2005). 
There are studies that failed to demonstrate the beneficial effect of omega-3 acids 
in reducing the cardiovascular death (the Diet and Reinfarction Trial II) (Burr et al 2003). 
A  Cochrane  meta-analysis  concluded  that  “there  is  not  enough  evidence  to  say  that 
people should stop taking rich sources of omega-3 fats, but further high quality trials are 
needed to confirm the previously suggested protective effect of omega-3 fats for those at 
increased cardiovascular risk” (Hopper et al 2004).   
Heart rate variability is a measure of cardiac electrophysiology
 that independently 
predicts sudden death in patients who suffer from cardiovascular diseases and
 reflects 
autonomic regulation related to respiratory, baroreflex,
 and circadian fluctuations and the 
underlying  cardiac  responses
  to  this  regulation  (Kleiger  2005).  One trial  found that  a 
greater consumption of tuna or other fish was associated with better values of heart rate 
variability indicators in older people (>65 years), independently from other cardiac risk 
factors (Mozaffarian et al 2008). This finding is very important because the prevalence of 
cardiovascular disease is much greater in the elderly.  
Several studies proved that omega-3 acids reduce the heart rate and reestablish 
faster the heart rate after exercises (O'Keefe et al 2006). A meta-analysis, performed in 
2005, showed that the reduction of heart rate was linked to a longer period of omega-3 
intake (> 12 weeks). This may be explained by the time needed by EPA and DHA to 
incorporate into the cells and to exert their effects. Heart rate was reduced in people with 
a  higher  baseline  heart  rate.  This  finding  shows  that  fish  oils  have  greater  effect  in 
people with “higher intrinsic sinus node automaticity, greater sympathetic tone, lower 
vagal tone, or lower ventricular efficiency” (Mozaffarian et al 2005). 
Omega-3 fatty acids produce a drastic
 reduction in fasting and postprandial serum 
triacylglycerols
  and  free  fatty  acids,  by  enrichment  in  platelet  phospholipids  and  by 
reducing  the  production  of  very  low  density  cholesterol  in  the  liver  [“suppression  of 
lipogenic genes
 and the induction of genes involved in fatty acid oxidation” (Barett et al 
2003)].  Omega-3  acids  have  a  positive  effect  on  the  increased
  lipolytic  activity  of 
lipoprotein  lipase  in  extrahepatic  tissues.  They  also  induce  changes  in  cellular  fatty 
partitioning,  initializing  the  oxidation  of  the  fat  tissue  and  the  reduction  of  the 
triacylglycerol synthesis. These changes determine a diminution of ectopic fat deposits 
and  organ  lipotoxicity  (Yvon  et  al  2006).  Several  studies  revealed  that  the 
supplementation of diet with fish oil reduces the level of seric triglycerides. 
 Fish oils lower blood pressure in humans, possibly by reducing systemic vascular 
resistance.  The  effect  is  small,  dose-dependent  and  the  extent  is  dependent  on  the 
degree  of  hypertension  (Kris-Etherton  et  al  2002).  Studies  showed  that  higher 
proportions  of  DHA,  found  in  erythrocyte  membrane,  were  associated  with  improved 
endothelial function, especially in smokers (Leeson et al 2002). Other studies reported 
improvements in arterial compliance, attenuation of the expression of cellular adhesion 
by vascular endothelium. A meta-regression analysis by Geleijnse in 2002 concludes that 
high intake of fish oil may lower  blood pressure, especially in older and hypertensive 
subjects (Geleijnse et al 2002). Another study showed that treatment with omega-3 fatty 
acids may reduce the continuous rise in blood pressure after heart transplant (Holm et al 
2001). 
Major epidemiologic studies proved the cardioprotective effect of EPA, DHA and fish 
intake on cardiovascular risk in healthy subjects: Nurses' Health Study, the Physicians' 
Health Study, the Cardiovascular Health Study, the Chicago Western
 Electric Study, an 
ecologic  study  by  Zhang  et  al,
  the  Japan  Public Health  Center-Based  Study
  Cohort  I. 
Some interventional trials supported the cardioprotective effect of fish oils: the Diet and 
Reinfarction Trial, the Japan EPA Lipid Intervention Study, GISSI-Prevenzione (Hu et al 
2002; Albert et al 1998; Lemaitre et al 2003; Daviglus et al 1997; Streppel et al 2008; 
Iso et al 2006). 
Besides the beneficial effect, a diet rich in fish oils can have negative repercussions. 
One  of  the  most  important  side  effects  is  the  ingestion  of  methylmercury,  found 
especially in predator fishes like shark, swordfish, marlin, large species of tuna, mackerel   141 
king. Methylmercury crosses the blood-brain barrier and the placenta (fetal risk), and can 
cause  cardiovascular  diseases  or  neurological  damage.  Many  agencies,  like  Food  and 
Drug  Administration,  European  Union  Health  and  Consumer  Protection  Directorate-
General and the World Health Organization issued guidelines to limit the methylmercury 
exposure. Pregnant women, nursing mothers and young children should avoid fish with 
high levels of methylmercury, should limit their intake of fish with moderate levels of 
methylmercury, and should consume fish with low levels of methylmercury no more than 
twice a week.  
One other important problem is that large-scale
 fishing can have ruinous effects on 
marine  ecosystems  and  their
  fish  populations.  Therefore  is  necessary  to  weight  the 
benefits  and  risk  of  eating  fish,  to  find  alternative  sources  of  omega-3  fatty  acids, 
although superior plants and algae do not have the same effect as fish oils (Brunner et al 
2008). 
The American Heart Association recommends that: “patients without documented 
coronary heart disease (CHD) eat a variety of (preferably fatty) fish at least twice a week 
(include oils and foods rich in alpha-linolenic acid: flaxseed, canola and soybean oils; 
flaxseed  and  walnuts).  Patients  with  documented  CHD  should  consume  about  1  g  of 
EPA+DHA  per  day,  preferably  from  fatty  fish.   EPA+DHA in  capsule  form could  be 
considered  in  consultation  with  the  physician. Patients  who  need  to  lower 
triglycerides should consume 2 to 4 grams of EPA+DHA per day provided as capsules 
under a physician’s care.”  (Kris-Etherton et al 2002). 
The European Society of Cardiology recommends that patients with stable angina 
without high risk factors should not receive omega-3 fatty acids supplementation, but 
they  should  consume  fish  at  least  once  a  week  (Fox  et  al  2006).  The  guideline  for 
management  of  patients  with  ventricular  arrhythmias  and  the  prevention  of  sudden 
cardiac  death  recommends  n-3  polyunsaturated  fatty  acid  supplementation  and 
underlying coronary heart  disease  (Zipes  et  al  2006).  The  guideline for  prevention  of 
cardiovascular disease concludes that omega-3 fatty acids showed protective
 effects on 
fatal events in patients who had suffered a previous
 myocardial infarction (Graham et al 
2007). 
  
Conclusion.  Omega-3  fatty  acids  are  a  valuable  mean  of  treating  and  preventing 
cardiovascular  diseases.  However,  larger  and  better  designed  studies  are  needed  to 
clarify some aspects of omega-3 acids protective effects.  
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